Tivozanib
Specifications
475108-18-0CAS Number
968-821-5EC Number
1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)ureaIUPAC Name
C22H19ClN4O5Chemical Formula
454.9 g/molMolecular Weight
Tivozanib; 475108-18-0; AV-951; KRN-951; AV951; KRN951; KIL8951; Kil-8951; AV951 cpd; DTXSID20963865; 172030934T; 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea; Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-; tivozanibum; 1-(2-chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methyl-1,2-oxazol-3-yl)urea; UREA, N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)-; RefChem:58429; DTXCID60205690; L01XE34; 968-821-5; Tivozanib (AV-951); 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea; AV 951; MFCD15146788; C22H19ClN4O5; N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA; KRN 951; CHEMBL1289494; AV-951;KRN951; 1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA; 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea; N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib [USAN]; ASP-4130; AV-951(Tivozanib); Tivozanib [USAN:INN]; Tivozanib HCl; 4ase; N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea; AV9; UNII-172030934T; OPHTHOTECH; AV-951,Tivozanib; TIVOZANIB [INN]; Tivozanib (USAN/INN); Tivozanib(AV-951)?; TIVOZANIB [WHO-DD]; MLS006011287; SCHEMBL172883; TIVOZANIB (OPHTHALMIC); Tivozanib - Bio-X trade mark; GTPL6058; orb1225002; orb1305458; SCHEMBL29354238; SCHEMBL29354604; CHEBI:91327; EX-A472; SPMVMDHWKHCIDT-UHFFFAOYSA-N; GLXC-90218; HMS3229O09; HMS3244C19; HMS3244C20; HMS3244D19; HMS3265A11; HMS3265A12; HMS3265B11; HMS3265B12; HMS3654G22; HMS3745C05; HMS5079O15; VEGFR Tyrosine Kinase Inhibitor IV; BDBM50331095; EBC-11349; NSC758007; NSC800952; s1207; AKOS022177607; CCG-206805; CS-0103; DB11800; EX-8600; NSC-758007; NSC-800952; PB28569; SDCCGSBI-0636568.P003; 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea; 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea; NCGC00249390-01; NCGC00249390-05; NCGC00249390-07; NCGC00249390-12; AC-24702; AS-16997; BP-44057; BT160380; BT300016; HY-10977; SMR004703037; SY122249; NS00068487; SW219364-1; D09683; EN300-18167318; Q7810457; BRD-K53414658-001-01-7; BRD-K53414658-001-08-2; N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea; 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea; DC-001164TIVOZANIBAV9511-(2-CHLORO-4((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-3-(5-METHYLISOXAZO-3-YL)UREA; N-(2-CHLORO-4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(5-METHYLISOXAZOL-3-YL)UREA; N-{2-Chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(5-methyl-1,2-oxazol-3-yl)ureaSynonyms
